Actively Recruiting
Effect of Hypoxic Conditioning on Cerebrovascular Health in the Elderly
Led by University Hospital, Grenoble · Updated on 2026-05-08
64
Participants Needed
1
Research Sites
254 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In line with the ever-growing aging of Western populations, the development of preventive strategies to slow down the effects of aging on cardiovascular health represents a major challenge in order to preserve functional capacities and a sufficient quality of life in the elderly. The alteration of vascular function (at the cerebral and systemic level) with aging is an important feature in the clinical picture including a decrease in physical and cognitive capacities. Although physical activity is recognized as an essential means of combating the effects of aging, optimizing its effects by defining the most effective strategies of practice remains a key objective. Offering alternative interventions to exercise training is also necessary for people who are unwilling or unable to engage in a physical activity program. In this context, hypoxic conditioning, alone or in conjunction with rehabilitative exercise training, is a new therapeutic modality with strong preclinical validity, in particular from a cardiovascular standpoint, and used in other pathologies to improve cardiovascular function and exercise performance and quality of life. Our aim is, therefore, to investigate the effect of hypoxic conditioning (alone or in conjunction with exercise training) on cerebrovascular health in the elderly.
CONDITIONS
Official Title
Effect of Hypoxic Conditioning on Cerebrovascular Health in the Elderly
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 60 and 80 years
- Physically inactive, less than 150 minutes of moderate to intense physical activity per week
- No chronic cardiovascular, respiratory, metabolic, or neuromuscular diseases that prevent exercise or hypoxic conditioning
- Have health coverage
- Able to provide written informed consent
You will not qualify if you...
- Body mass index greater than 30 kg/m2
- Smoking more than specified amount of cigarettes per day
- Alcohol consumption exceeding 10 grams per day
- Mental disorder or history of mental disorder
- Taking beta-blocker medications
- Unable or unwilling to provide informed consent
- No health coverage
- Exceeding annual allowance limits from other clinical trial participation
- Deprived of freedom by judicial or administrative decision
- Under legal protection preventing clinical trial participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Grenoble Alpes
La Tronche, Auvergne-Rhône-Alpes, France, 38700
Actively Recruiting
Research Team
S
Stéphane Doutreleau, MD, PhD
CONTACT
S
Samuel Vergès, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here